rs11539148

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005051.3(QARS1):​c.854A>G​(p.Asn285Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0547 in 1,613,540 control chromosomes in the GnomAD database, including 2,813 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.040 ( 169 hom., cov: 33)
Exomes 𝑓: 0.056 ( 2644 hom. )

Consequence

QARS1
NM_005051.3 missense

Scores

2
3
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 5.76

Publications

29 publications found
Variant links:
Genes affected
QARS1 (HGNC:9751): (glutaminyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
QARS1 Gene-Disease associations (from GenCC):
  • diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • microcephaly-short stature-intellectual disability-facial dysmorphism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056907833).
BP6
Variant 3-49101377-T-C is Benign according to our data. Variant chr3-49101377-T-C is described in ClinVar as Benign. ClinVar VariationId is 380108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0605 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005051.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
QARS1
NM_005051.3
MANE Select
c.854A>Gp.Asn285Ser
missense
Exon 10 of 24NP_005042.1P47897-1
QARS1
NM_001272073.2
c.821A>Gp.Asn274Ser
missense
Exon 10 of 24NP_001259002.1P47897-2
QARS1
NR_073590.2
n.829A>G
non_coding_transcript_exon
Exon 10 of 24

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
QARS1
ENST00000306125.12
TSL:1 MANE Select
c.854A>Gp.Asn285Ser
missense
Exon 10 of 24ENSP00000307567.6P47897-1
QARS1
ENST00000464962.6
TSL:1
c.419A>Gp.Asn140Ser
missense
Exon 9 of 23ENSP00000489011.1B4DDN1
QARS1
ENST00000965966.1
c.977A>Gp.Asn326Ser
missense
Exon 10 of 24ENSP00000636025.1

Frequencies

GnomAD3 genomes
AF:
0.0398
AC:
6062
AN:
152192
Hom.:
169
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0109
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.0230
Gnomad ASJ
AF:
0.0528
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.0145
Gnomad FIN
AF:
0.0648
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0620
Gnomad OTH
AF:
0.0363
GnomAD2 exomes
AF:
0.0397
AC:
9981
AN:
251102
AF XY:
0.0401
show subpopulations
Gnomad AFR exome
AF:
0.0105
Gnomad AMR exome
AF:
0.0182
Gnomad ASJ exome
AF:
0.0496
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0659
Gnomad NFE exome
AF:
0.0581
Gnomad OTH exome
AF:
0.0448
GnomAD4 exome
AF:
0.0563
AC:
82225
AN:
1461230
Hom.:
2644
Cov.:
31
AF XY:
0.0548
AC XY:
39829
AN XY:
726934
show subpopulations
African (AFR)
AF:
0.00849
AC:
284
AN:
33462
American (AMR)
AF:
0.0179
AC:
799
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.0521
AC:
1360
AN:
26122
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39692
South Asian (SAS)
AF:
0.0145
AC:
1246
AN:
86228
European-Finnish (FIN)
AF:
0.0646
AC:
3449
AN:
53412
Middle Eastern (MID)
AF:
0.0103
AC:
59
AN:
5756
European-Non Finnish (NFE)
AF:
0.0649
AC:
72184
AN:
1111512
Other (OTH)
AF:
0.0468
AC:
2828
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3672
7344
11015
14687
18359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2656
5312
7968
10624
13280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0398
AC:
6063
AN:
152310
Hom.:
169
Cov.:
33
AF XY:
0.0389
AC XY:
2897
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0109
AC:
453
AN:
41582
American (AMR)
AF:
0.0229
AC:
351
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0528
AC:
183
AN:
3468
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5190
South Asian (SAS)
AF:
0.0149
AC:
72
AN:
4832
European-Finnish (FIN)
AF:
0.0648
AC:
687
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0620
AC:
4219
AN:
68020
Other (OTH)
AF:
0.0360
AC:
76
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
298
596
894
1192
1490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0495
Hom.:
521
Bravo
AF:
0.0344
TwinsUK
AF:
0.0618
AC:
229
ALSPAC
AF:
0.0682
AC:
263
ESP6500AA
AF:
0.0141
AC:
62
ESP6500EA
AF:
0.0572
AC:
492
ExAC
AF:
0.0390
AC:
4732
Asia WGS
AF:
0.00895
AC:
31
AN:
3478
EpiCase
AF:
0.0549
EpiControl
AF:
0.0539

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.77
D
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.015
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
5.8
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-4.4
D
REVEL
Benign
0.19
Sift
Benign
0.27
T
Sift4G
Benign
0.39
T
Polyphen
0.054
B
Vest4
0.45
MPC
0.30
ClinPred
0.040
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.69
gMVP
0.90
Mutation Taster
=73/27
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11539148; hg19: chr3-49138810; COSMIC: COSV107380589; COSMIC: COSV107380589; API